Seattle Genetics Cancer-Drug Trials on Hold After Four Patient Deaths

Seattle Genetics Inc. said the U.S. Food and Drug Administration had placed several of its early-stage cancer drug trials on hold after four patients died during treatment.

from WSJ.com: US Business http://ift.tt/2ip53Iy
via IFTTT